Advisory - "Thyroid Gland" no longer authorized for sale - WSFA.com Montgomery Alabama news.

Advisory - "Thyroid Gland" no longer authorized for sale

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

OTTAWA, May 13, 2014 /CNW/ -

The issue:

Health Canada has requested a stop sale and recall of the product "Thyroid Gland" (NPN 80044198). The action has been taken because the product contains the prescription drug ingredient thyroid. Products containing thyroid hormone should be used with caution in diabetics, the elderly and patients with high blood pressure.

While the product was authorized as a Natural Health Product by Health Canada, products that contain prescription drug ingredients are subject to different regulatory requirements and review practices than natural health products in assessing their safety, quality and efficacy. Therefore authorization of "Thyroid Gland" as a Natural Health Product has been rescinded.

Who is affected:

Canadians who have used or purchased Life Choice Ltd.'s product, "Thyroid Gland".

What consumers should do:
  • Speak to your healthcare practitioner about any questions or concerns regarding this product.
  • Report any adverse events using this product to Health Canada.

What Health Canada is doing:

Health Canada has requested that the authorization holder, Life Choice Ltd., recall "Thyroid" Gland and refrain from selling it on its website or elsewhere. As of today, the recall and stop-sale has not been initiated by Life Choice.

Background:

There are risks with taking this health product - as it contains a prescription drug ingredient - without supervision by a healthcare professional.

"Thyroid Gland" contains hormones commonly used to treat decreased or absent thyroid function, called hypothyroidism. Products containing thyroid hormone should be used with caution in patients also using medication to treat diabetes and blood-clotting. There is also a risk to patients with cardiac conditions such as angina pectoris, high blood pressure and in the elderly as they have a greater likelihood of heart conditions.

Health Canada has not received any reports of adverse reactions associated with the use of this product.

For more information:

Consumers and health professionals wanting more information about this advisory from Health Canada can contact the Public Enquiries Line at 613-957-2991, or toll free at 1-866-225-0709.

Media enquiries related to this Advisory should be directed to Health Canada Media Relations at 613-957-2983.

How to report side effects of health products to Health Canada:

  • Call toll-free at 1-866-234-2345
  • Visit MedEffect Canada's web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.

Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.

SOURCE Health Canada

PDF available at: http://stream1.newswire.ca/media/2014/05/13/20140513_C8180_DOC_EN_40256.pdf

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow